Acetylcholine stim 
Welcome,         Profile    Billing    Logout  
  Companies    Products    Diseases    Trials    News 
3 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Firdapse (amifampridine) / BioMarin, Catalyst Pharma
NCT03579966 / 2017-004777-14: Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis)

Active, not recruiting
3
70
US
Amifampridine Phosphate
Catalyst Pharmaceuticals, Inc., Catalyst Pharmaceuticals Inc.
Myasthenia Gravis, MuSK
12/21
06/22
SMA3, NCT03819660: Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3

Enrolling by invitation
2
12
Europe
Amifampridine Phosphate 10 MG Oral Tablet
Catalyst Pharmaceuticals, Inc.
Muscle Atrophy
12/21
04/22
EAP-001, NCT02189720: Expanded Access Study Amifampridine Phosphate in Congenital Myasthenic Syndrome (CMS)

No Longer Available
N/A
US
Amifampridine Phosphate, 3,4-Diaminopyridine Phosphate, 3,4 DAP
Catalyst Pharmaceuticals, Inc.
Congenital Myasthenic Syndrome
 
 

Download Options